The International Diabetes Federation brings its World Diabetes Congress to Montreal in October

Held in cooperation with the Canadian Diabetes Association and Diabète Québec, the 20th World Diabetes Congress in Montreal will be one of the world's largest medical conferences - a mega-event that is expected to attract over 15,000 delegates to the city from October 18 to 22, 2009. Key opinion leaders from the global diabetes community - from over 160 countries - will converge on Montreal to discuss the burning issues in diabetes.

Organized by the International Diabetes Federation every two years, the World Diabetes Congress will highlight the latest developments in clinical research, showcase new data on the diabetes pandemic, and promote political action to tackle diabetes. Health ministers and officials will join the world’s leading diabetes experts to share knowledge, experiences and innovative solutions to address the diabetes threat.

The World Diabetes Congress is the premier gathering of the global diabetes community. It is an honour and a privilege to bring the congress to a place of such historical importance to the diabetes world. We will be covering a wide range of diabetes-related issues, topics and so much more, making the event bigger and better than ever,” said Dr. Linda Siminerio, Chair of the IDF Congress Organizing Committee.

The Congress will be held at the Palais des Congrès de Montréal and will feature a 12,000 sq m exhibition area. Delegates and exhibitors will not only spend the week sharing information, catching up with old friends, and making new ones, but also provide a welcome boost to the local economy as they enjoy the hospitality, fine dining and sightseeing opportunities that make Montreal such an attractive venue.

"We are thrilled that the IDF has chosen Montreal, a leader in the life sciences, to host the prestigious 20th World Diabetes Congress," says Charles Lapointe, President and CEO of Tourisme Montréal. "We look forward to welcoming these thousands of WDC delegates and sharing the excitement of our city, from its gourmet dining to its shopping and culture, to a downtown that hums with round-the-clock action. It will be at least another decade before this distinguished meeting is held in North America again, so we intend to roll out the red carpet and leave our guests with unforgettable Montreal memories."

Diabetes in Canada
North America has one of the highest prevalence rates of diabetes in the world, with over 9% of the adult population living with diabetes. In Canada, 9.3% of adults currently have diabetes and this figure is expected to rise to 11.1% by 2025 according to IDF.

According to the Canadian Diabetes Association and Diabète Québec more than 2.4 million Canadians are living with diabetes. In addition, more than 6 million Canadians have pre-diabetes, placing them at significant risk of developing type 2 diabetes. Particularly alarming is that nearly 80 percent of new Canadians arrive from populations at high risk of diabetes (Asian, South Asian, African, or Hispanic descent).

As the birthplace of hope for the millions affected by diabetes around the world, Canada is proud to host the International Diabetes Federation's 20th World Diabetes Congress this October," said Ellen Malcolmson, President and CEO, Canadian Diabetes Association. "Our founder, Charles Best, the co-discoverer of insulin, saw that the growing numbers of Canadians with diabetes required an organization to serve their needs. Today, diabetes is nothing short of a global pandemic. By bringing thought leaders together in Montreal, IDF is serving the needs of the global community and ultimately, the people who are striving to live healthy lives while we search for a cure."

The prevalence of diabetes is growing at a faster rate than expected around the world." said Serge Langlois, President and CEO of Diabete Québec, "Over the years, our organization has expended tremendous efforts to raise awareness about this reality: by educating persons living with diabetes as well as the health care professionals involved; by providing access to the right treatment and by assisting in the fight against discrimination toward those affected. This World Diabetes Congress will focus on such issues and therefore, we are proud to welcome to Montreal people of the world who are sharing in the ongoing fight against diabetes."

With over 250 million worldwide with diabetes and 380 million expected by 2025, the fight against the diabetes epidemic continues. The World Diabetes Congress is the place to join that fight. "Canada holds a special place in the heart of the diabetes community. We welcome the participation of people living with diabetes and have sessions dedicated to them. The World Diabetes Congress is a unique event for everyone affected by diabetes and concerned with making a difference to improve diabetes care," said Dr. Siminerio.

To find out more about the World Diabetes Congress and to register, please visit:
www.worlddiabetescongress.org

Most Popular Now

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...